Allogene Therapeutics
ALLO
ALLO
95 hedge funds and large institutions have $1.87B invested in Allogene Therapeutics in 2019 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 36 increasing their positions, 25 reducing their positions, and 10 closing their positions.
Holders
95
Holders Change
+1
Holders Change %
+1.06%
% of All Funds
2.09%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.09%
New
12
Increased
36
Reduced
25
Closed
10
Calls
$10.7M
Puts
$2.28M
Net Calls
+$8.45M
Net Calls Change
+$7.85M
Top Buyers
| 1 |
1
Vanguard Group
Malvern,
Pennsylvania
|
$108M |
| 2 |
2
Capital World Investors
Los Angeles,
California
|
$89.3M |
| 3 |
3
BlackRock
New York
|
$109M |
| 4 |
WCM
4
Wildcat Capital Management
New York
|
$24.7M |
| 5 |
5
Norges Bank
Oslo,
Norway
|
$27.7M |
Top Sellers
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
MWNA
101
Marshall Wace North America
New York
| – | – | -9,531 | Closed |
|
|
QT
102
Quantbot Technologies
New York
| – | – | -3,600 | Closed |
|
103
Canada Life
Winnipeg,
Manitoba, Canada
| – | – | -3,067 | Closed |
|
|
PRC
104
Pearl River Capital
Niles,
Michigan
| – | – | -748 | Closed |
|
105
Simplex Trading
Chicago,
Illinois
| – | – | -157 | Closed |
|
|
CM
106
Caption Management
Oklahoma City,
Oklahoma
| – | – | – | – |
|
107
Nomura Asset Management
Tokyo,
Japan
| – | – | – | – |
|
|
CFGS
108
Concourse Financial Group Securities
Birmingham,
Alabama
| – | – | – | – |
|
109
Millennium Management
New York
| – | – | – | – |
|